Galapagos NV (GLPG) EPS Estimated At $-0.47; Rutabaga Capital Management Lifted Granite Construction (GVA) Stake By $1.53 Million

Galapagos NV (NASDAQ:GLPG) Logo Rutabaga Capital Management Llc increased Granite Construction Inc (GVA) stake by 10.93% reported in 2018Q3 SEC filing. Rutabaga Capital Management Llc acquired 33,900 shares as Granite Construction Inc (GVA)’s stock declined 4.46%. The Rutabaga Capital Management Llc holds 344,038 shares with $15.72M value, up from 310,138 last quarter. Granite Construction Inc now has $2.06B valuation. The stock decreased 0.09% or $0.04 during the last trading session, reaching $43.89. About 181,453 shares traded. Granite Construction Incorporated (NYSE:GVA) has declined 33.41% since January 28, 2018 and is downtrending. It has underperformed by 33.41% the S&P500. Some Historical GVA News: 30/04/2018 – Granite Construction Sees 2018 Low-Double Digit Consolidated Rev Growth; 22/03/2018 – Granite Construction Closes Below 200-Day Average: Technicals; 03/04/2018 – GRANITE CONSTRUCTION INC SAYS TRANSACTION IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO GRANITE’S 2018 EARNINGS PER SHARE; 30/04/2018 – GRANITE CONSTRUCTION 1Q REV. $563.4M, EST. $525.9M; 30/04/2018 – Granite Construction 1Q Loss/Shr 29c; 23/04/2018 – Granite Announces Planned Retirement Of Chief Financial Officer; 01/05/2018 – Forbes Names Granite One of America’s Best Mid-Size Employers for the Third Year in a Row; 23/04/2018 – GRANITE REPORTS PLANNED RETIREMENT OF CFO; 20/03/2018 – CETUS CAPITAL lll LP REPORTS 7.8 PCT STAKE IN LAYNE CHRISTENSEN CO AS OF MARCH 13; 16/04/2018 – Granite Announces Timing of Earnings Release and Investor Conference Call

Analysts expect Galapagos NV (NASDAQ:GLPG) to report $-0.47 EPS on February, 28.They anticipate $0.22 EPS change or 31.88% from last quarter’s $-0.69 EPS. After having $0.33 EPS previously, Galapagos NV’s analysts see -242.42% EPS growth. The stock increased 1.03% or $1.06 during the last trading session, reaching $103.65. About 96,807 shares traded. Galapagos NV (NASDAQ:GLPG) has risen 20.27% since January 28, 2018 and is uptrending. It has outperformed by 20.27% the S&P500. Some Historical GLPG News: 28/03/2018 – Breitbart News: Exclusive – Rep. Paul Gosar: `This Two-Year Budget Is a Huge Albatross’; 30/05/2018 – Gilead and Galapagos Announce Results With Filgotinib in the Phase 2 Equator Study in Psoriatic Arthritis and Progression Into Phase 3 for the Selection Study in Ulcerative Colitis; 04/05/2018 – EUR HIGH YIELD: Galapagos Among Thursday’s Biggest Decliners; 12/04/2018 – GALAPAGOS NV – PHASE 3 PROGRAM IS EXPECTED TO START DOSING IN SECOND HALF OF 2018; 30/05/2018 – GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGR; 30/05/2018 – GILEAD, GALAPAGOS: EQUATOR ACHIEVES PRIMARY ENDPOINT OF ACR20; 19/04/2018 – GALAPAGOS NV GLPG.AS – WARRANTS HAVE AN EXERCISE TERM OF EIGHT YEARS AS OF DATE OF OFFER AND HAVE AN EXERCISE PRICE OF EUR 79.88; 30/05/2018 – REG-GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS; 27/04/2018 – GALAPAGOS NV GLPG.AS – GLPG1972 WAS ALSO FOUND TO DISPLAY A PROTECTIVE EFFECT TOWARDS OA BONE REMODELING; 24/04/2018 – REG-Galapagos reports initiation of FALCON clinical trial in cystic fibrosis

More notable recent Galapagos NV (NASDAQ:GLPG) news were published by: Seekingalpha.com which released: “Galapagos teams up with Fibrocor in fibrosis – Galapagos (NASDAQ:GLPG) – Seeking Alpha” on January 04, 2019, also Globenewswire.com with their article: “Galapagos starts first Phase 1 trial with Toledo compound – GlobeNewswire” published on January 07, 2019, Nasdaq.com published: “Sands Capital reports 5.7% holding in Galapagos – Nasdaq” on January 08, 2019. More interesting news about Galapagos NV (NASDAQ:GLPG) were released by: Nasdaq.com and their article: “The Math Shows ADRU Can Go To $23 – Nasdaq” published on January 03, 2019 as well as Streetinsider.com ‘s news article titled: “Nomura/Instinet Remains Bullish on Galapagos NV (GLPG); Expects 2Q NDA Submission – StreetInsider.com” with publication date: January 03, 2019.

Among 6 analysts covering Galapagos ( NASDAQ:GLPG ), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Galapagos had 9 analyst reports since August 6, 2018 according to SRatingsIntel. The stock has “Outperform” rating by Credit Suisse on Thursday, December 13. The firm has “Neutral” rating by Credit Suisse given on Friday, October 26. Stifel Nicolaus maintained Galapagos NV (NASDAQ:GLPG) on Wednesday, September 12 with “Buy” rating. Morgan Stanley maintained the shares of GLPG in report on Monday, August 6 with “Overweight” rating. Nomura maintained it with “Buy” rating and $140 target in Tuesday, October 30 report. The stock has “Neutral” rating by Credit Suisse on Tuesday, August 7. As per Monday, November 5, the company rating was maintained by Morgan Stanley.

Galapagos NV, a clinical-stage biotechnology company, develops and commercializes novel medicines in Belgium, Croatia, France, and the Netherlands. The company has market cap of $5.61 billion. The Company’s clinical stage programs include filgotinib, which is in Phase III clinical trial for the treatment of rheumatoid arthritis, Crohn’s disease, and ulcerative colitis; GLPG1690, which is in Phase IIa clinical trial for the treatment of idiopathic pulmonary fibrosis; GLPG1972, which is in Phase 1 clinical trial for the treatment of osteoarthritis; and MOR106 that is in atopic dermatitis patients in Phase Ib trial. It currently has negative earnings. The firm has collaboration agreement with Gilead Sciences, Inc. for the development of filgotinib for inflammatory indications; Servier to develop GLPG1972; and AbbVie for discovery, development, and commercialization of potentiator and corrector molecules for the treatment of cystic fibrosis, as well as with MorphoSys for MOR106.

Among 2 analysts covering Granite Construction ( NYSE:GVA ), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Granite Construction had 2 analyst reports since August 10, 2018 according to SRatingsIntel. The firm has “Neutral” rating by Goldman Sachs given on Monday, December 10. Canaccord Genuity maintained Granite Construction Incorporated (NYSE:GVA) rating on Friday, August 10. Canaccord Genuity has “Buy” rating and $65 target.

Rutabaga Capital Management Llc decreased Northern Technologies Intl (NASDAQ:NTIC) stake by 28,292 shares to 160,543 valued at $5.57M in 2018Q3. It also reduced Qad Inc (NASDAQ:QADA) stake by 10,100 shares and now owns 112,416 shares. Lindblad Expeditions Holdings Inc. was reduced too.

Investors sentiment decreased to 1.13 in 2018 Q3. Its down 0.91, from 2.04 in 2018Q2. It dropped, as 38 investors sold GVA shares while 63 reduced holdings. 36 funds opened positions while 78 raised stakes. 42.61 million shares or 3.05% more from 41.34 million shares in 2018Q2 were reported. Hightower Advisors Limited Co, a Illinois-based fund reported 8,448 shares. Ameriprise Fin holds 0.02% or 1.04 million shares in its portfolio. Evergreen Management Ltd Liability Co holds 38,510 shares. Hartford Management Incorporated holds 0% or 100 shares. Personal Cap Advisors holds 0.02% or 32,956 shares. Raymond James & Assocs holds 8,754 shares. Tower Research Limited Liability Company (Trc) reported 0.01% of its portfolio in Granite Construction Incorporated (NYSE:GVA). Riverhead Limited Liability Company has 0.01% invested in Granite Construction Incorporated (NYSE:GVA). 1.45M are owned by Wellington Grp Llp. Agf Investments stated it has 404 shares. Stevens Cap Mgmt Limited Partnership accumulated 14,301 shares. Northern Tru holds 0.01% in Granite Construction Incorporated (NYSE:GVA) or 1.25 million shares. Tradition Cap Management Ltd Liability has 17,450 shares. California Employees Retirement System holds 0.01% or 119,728 shares. Alliancebernstein Limited Partnership owns 0.05% invested in Granite Construction Incorporated (NYSE:GVA) for 1.67M shares.

Since November 26, 2018, it had 0 buys, and 2 sales for $174,581 activity. Roberts James Hildebrand also sold $57,805 worth of Granite Construction Incorporated (NYSE:GVA) on Tuesday, November 27. Granite Construction Incorporated (NYSE:GVA) Institutional Positions Chart

Click Here to Continue...


Add a Comment

Your email address will not be published. Required fields are marked *